S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%
A daily business newspaper · Founded in 2026

Money Talk

Finance and markets: business, quotes, gold, energy and releases.

Vanda Pharmaceuticals Sets August 5 Date for Q2 Earnings

Washington-based Vanda Pharmaceuticals will disclose its financial performance for the second quarter of 2026 on August 5, immediately following the closing of the market. The announcement precedes a scheduled conference call where executives plan to outline the company's fiscal standing and recent corporate developments to investors.

Vanda Pharmaceuticals Sets August 5 Date for Q2 Earnings
Photo: Bio & News

The conference call is set to begin at 4:30 PM ET. Participants can join the discussion by dialing 1-888-596-4144 domestically or 1-646-968-2525 for international callers, using the passcode 1843107. A live audio webcast will be available on the company website, where early registration is recommended to ensure proper software configuration.

For those unable to attend the live session, a replay will be accessible starting at 8:30 PM ET on August 5 through August 12. Domestic listeners can access the recording at 1-800-770-2030, while international callers should use 1-609-800-9909, referencing the same passcode. Vanda, currently focused on developing therapies for unmet medical needs, will provide further details on their portfolio during the presentation.

Share article
TelegramXFacebook

When reusing this material a link to Money Talk is required.

Comments (0)

Leave a comment

No comments yet. Be the first!